Mark J Enyedy Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark J Enyedy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark J Enyedy. Mark J Enyedy is an Chief Executive Officer in IMMUNOGEN INC ($IMGN) and a Director in KERYX BIOPHARMACEUTICALS INC ($KERX) and a Director in FATE THERAPEUTICS INC ($FATE) and a in Akebia Therapeutics, Inc. ($AKBA) and a Director in Akebia Therapeutics, Inc. ($AKBA) and a Director in LogicBio Therapeutics, Inc. ($LOGC).
Address: C/O FATE THERAPEUTICS, INC. 3535 GENERAL ATOMICS COURT, SUITE 200 SAN DIEGO 92121 CA
Companies in which Mark J Enyedy is an Insider
Akebia Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark J Enyedy:
Holdings: 31,143 shares
Current Value: $307,693
Latest Transaction: Jun 09 2020
$AKBA Market Capitalization: $177.33M
$AKBA Previous Close: $9.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
FATE THERAPEUTICS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark J Enyedy: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 04 2017
$FATE Market Capitalization: $95.27M
$FATE Previous Close: $2.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ImmunoGen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark J Enyedy: Chief Executive Officer
Holdings: 429,017 shares
Current Value: $1,021,060
Latest Transaction: Feb 09 2021
$IMGN Market Capitalization: $205.16M
$IMGN Previous Close: $2.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KERYX BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark J Enyedy: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Dec 13 2018
$KERX Market Capitalization: $574.30M
$KERX Previous Close: $5.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
LogicBio Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark J Enyedy: Director
Holdings: 2,921 shares
Latest Transaction: Jun 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark J Enyedy
Sentiment: All, AKBA, FATE, IMGN, KERX, LOGC
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | LOGC | LogicBio Therapeut ... | Enyedy Mark J | Director | Option Exercise | A | 4.59 | 12,500 | 57,375 | 12,500 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Option Exercise | A | 7.69 | 925,000 | 7,113,250 | 925,000 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 429,017 | 439 K to 429 K (-2.28 %) |
| Jan 04 2021 | LOGC | LogicBio Therapeut ... | Enyedy Mark J | Director | Option Exercise | M | 0.00 | 2,921 | 0 | 0 | |
| Jan 04 2021 | LOGC | LogicBio Therapeut ... | Enyedy Mark J | Director | Buy | M | 0.00 | 2,921 | 0 | 2,921 | 0 to 2.9 K |
| Jul 02 2020 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Grant | A | 3.91 | 5,241 | 20,492 | 439,017 | 433.8 K to 439 K (+1.21 %) |
| Jun 23 2020 | LOGC | LogicBio Therapeut ... | Enyedy Mark J | Director | Option Exercise | A | 0.00 | 2,921 | 0 | 2,921 |